Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4696106012 | Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 4696107015 | Calamine 150 mg/mL and zinc oxide 50 mg/mL cutaneous lotion | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Is a | Medicinal product (product) | true | Inferred relationship | Some | ||
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | Conventional release cutaneous lotion (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has basis of strength substance (attribute) | Calamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has precise active ingredient | Calamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has basis of strength substance (attribute) | Zinc oxide | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has precise active ingredient | Zinc oxide | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR